Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy

British Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 486-494

  Turner, J H ^a,c   Rose, A H ^a   Glancy, R J ^a   Penhale, W J ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b MURDOCH UNIVERSITY   (Australia)

^c FREMANTLE HOSPITAL   (Australia)

Author keywords

Human tumour xenografts; Large animal model; Ovine orthotopic transplantation; Radioimmunotherapy; Sheep

Indexed keywords

CYCLOSPORIN; KETOCONAZOLE; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HT29; COLON CARCINOMA; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MELANOMA; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARY CARCINOMA; PERITONEUM; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SHEEP; XENOGRAFT;

EID: 0031825772     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.520     Document Type: Article

References (26)

1. Begent RHJ and Pedley RB (1990) Antibody targeted therapy in cancer: comparison of murine and clinical studies. Cancer Treat Rev 17: 373-378
2. Begent RHJ, Ledermann JA, Green AJ, Bagshawe KD, Riggs SJ, Searle F, Keep PA, Adam T, Dale RG and Glaser MG (1989) Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. Br J Cancer 60: 406-412
3. 131I-labelled monoclonal antibodies. Cancer Res 52: 6036-6044
4. DeNardo GL, Kroger LA, DeNardo SJ, Miers LA, Salako Q, Kukis DL, Fand I, Shen S, Renn O and Meares CF (1994) Comparative toxicity studies of Yurium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Cancer 73 (suppl.): 1012-1022
5. Dykes PW, Bradwell AR, Chapman CE and Vaughan ATM (1987) Radioimmunotherapy of cancer: clinical studies and limiting factors. Cancer Treat Rev 14: 87-106
6. Fidler I (1990) Critical factors in the biology of human cancer metastasis: Twentyeighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 50: 6130-6138
7. Fridman R, Kibbey MC, Royce LS, Thomas MZ, Sweeney M, Jicba DL, Yanelli JR, Martin GR and Kleinman UK (1991) Enhanced tumour growth of both primary and established human and murine tumour cells in athymic mice after coinjection with matrigel. J Natl Cancer Inst 83: 769-774
8. Fu X, Besterman JM, Monosov A and Hoffman RM (1991) Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci USA 88: 9345-9349
9. Kallinowski F, Schlenger KH, Runkel S, Kloes M, Stohrer M, Okunieff P and Vaupel P (1989) Blood flow metabolism, cellular microenvironment and growth rate of human tumour xenografts. Cancer Res 49: 3759-3764
10. Knox SJ (1995) Overview of studies on experimental radioimmunotherapy. Cancer Res 55 (suppl.): 5832-5836
11. Kubota T (1994) Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem 56: 4-8
12. 2 antibodies. Br J Cancer 70: 521-525
13. Ledermann JA, Begent RHJ, Massof C, Kelly AMB, Adam T and Bagshawe KD (1991) A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune response. Int J Cancer 47: 659-664
14. Manzotti C, Riccardo A and Pratesi G (1993) Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion. Clin Exp Metastasis 11: 5 14
15. O'Donoghue HL, Penhale WJ, Manning LS, Reynoldson JA and Turner JH (1996) Cyclosporine A immunosuppression in sheep with response enhancement by concomitant ketoconazole. Clin Exp Pharmacol Physiol 23: 797-803
16. Pedley RB, Boden J, Keep PA, Harwood PJ, Green AJ and Rogers GT (1987) Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft. Eur J Nucl Med 13: 197-202
17. 131I anti-CEA antibody in a colonic xenograft model. Br J Cancer 68: 69-73
18. Rygaard J and Povlsen CO (1969) Heterotransplantation of a human malignant tumour to nule mice. Acta Pathol Microbiol Scand 77: 758-760
19. Schroeder TJ, Melvin DB, Clardy CW, Wadhwa NK, Myre SA, Reising JM, Wolf RK, Collins JA, Pesce AJ and First MR (1987) Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients. J Heart Transplant 6: 84-89
20. Senekowitsch R, Reidel G, Mollenstadt S, Kriegal H and Pabst HW (1989) Curative radioimmunotherapy of human mammary carcinoma xenografts with Iodine 131-labeled monoclonal antibodies. J Nucl Med 30: 531-537
21. Sgouros G (1995) Radioimmunotherapy of micrometastases: side-stepping the solid-tumour hurdle. J Nucl Med 36: 1910-1912
22. Siler K, Eggensperger D, Hand PH, Milenic DE, Miller LS, Houchens DP, Hinkle G and Schlom J (1993) Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1). Biotech Ther 4: 163-181
23. Vaughan ATM, Bradwell AR, Dykes PW and Anderson P (1986) Illusions of tumour killing using radiolabeled antibodies. Lancet 1: 1492-1493
24. Wahl RL (1994) Experimental radioimmunotherapy. Cancer 73 (suppl.): 989-992
25. Ward BG, Wallace K, Shepherd JH and Balkwill FR (1987) Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res 47: 2662-2667
26. Yu B, Carrasquillo J, Milenic D, Chung Y, Perentesis P, Feuerestein I, Eggensperger D, Qi C-F, Paik C, Reynold J, Grem J, Curt G, Siler K, Schlom J and Allegra C (1996) Phase I trial of Iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumour bulk on pharmacokinetics. J Clin Oncol 14: 1798-1809